{"indexed":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T20:40:11Z","timestamp":1526935211585},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"published-print":{"date-parts":[[2018,5,22]]},"DOI":"10.1212\/wnl.0000000000005569","type":"article-journal","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T20:15:19Z","timestamp":1526933719000},"page":"989.2-989","update-policy":"http:\/\/dx.doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":"Editors' note: Anti-cytosolic 5\u2032-nucleotidase 1A (cN1A) autoantibodies in motor neuron diseases","prefix":"10.1212","volume":"90","author":[{"given":"Chafic","family":"Karam","sequence":"first","affiliation":[]},{"given":"Steven","family":"Galetta","sequence":"additional","affiliation":[]}],"member":"276","published-online":{"date-parts":[[2018,5,21]]},"container-title":"Neurology","original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1212\/WNL.0000000000005569","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T20:15:20Z","timestamp":1526933720000},"score":1.0,"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":0,"journal-issue":{"published-online":{"date-parts":[[2018,5,21]]},"published-print":{"date-parts":[[2018,5,22]]},"issue":"21"},"alternative-id":["10.1212\/WNL.0000000000005569"],"URL":"http:\/\/dx.doi.org\/10.1212\/wnl.0000000000005569","relation":{},"ISSN":["0028-3878","1526-632X"],"container-title-short":"Neurology"}